Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation

Key Points

• This research aims to compare the outcomes of temporarily interrupting rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation.
• Randomized trial with patients having nonvalvular atrial fibrillation
• Comparison of temporary interruption of rivaroxaban and continued warfarin
• NCT00403767 eligibility and assessment criteria
• Significant differences in bleeding events between groups
• Rivaroxaban interruption leads to lower hospitalization rates
• Improved thromboembolic outcomes observed with rivaroxaban